Pablo J. Cagnoni
VP & Chief Medical Officer, OSI PHARMACEUTICALS INC.
Companies
- IncytePresident Jun 7, 2023 to now1
- Fusion Pharmaceuticals Inc.Board member Jun 25, 2020 to Jun 4, 20242
- Rubius Therapeutics (United States)Board member Jul 17, 2018 to Feb 1, 20233
- Rubius Therapeutics (United States)President Apr 15, 2020 to Feb 14, 20224
- Rubius Therapeutics (United States)Chief executive officer Jul 17, 2018 to Feb 14, 20223
- TURMERIC ACQUISITION CORP.Board member Oct 15, 2020 to Oct 15, 20205
- CRISPR TherapeuticsBoard member Oct 18, 2016 to Nov 21, 20196
- Onyx PharmaceuticalsEVP, Global R&D and Tech Ops Mar 13, 2013 to Oct 3, 20137
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARIncyte, President
- 2
- 3
- 4
- 5
- 6SEC EDGARCRISPR Therapeutics, Board member
- 7